233 related articles for article (PubMed ID: 28550452)
1. Evaluation of Long-Term Outcomes of Microsatellite Instability Status in an Asian Cohort of Sporadic Colorectal Cancers.
Tan WJ; Hamzah JL; Acharyya S; Foo FJ; Lim KH; Tan IBH; Tang CL; Chew MH
J Gastrointest Cancer; 2018 Sep; 49(3):311-318. PubMed ID: 28550452
[TBL] [Abstract][Full Text] [Related]
2. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.
Des Guetz G; Schischmanoff O; Nicolas P; Perret GY; Morere JF; Uzzan B
Eur J Cancer; 2009 Jul; 45(10):1890-6. PubMed ID: 19427194
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit.
Thomas ML; Hewett PJ; Ruszkiewicz AR; Moore JW
Asia Pac J Clin Oncol; 2015 Dec; 11(4):343-51. PubMed ID: 26471980
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of carcinoembryonic antigen is influenced by microsatellite instability genotype and stage in locally advanced colorectal cancers.
Søreide K; Søreide JA; Kørner H
World J Surg; 2011 Apr; 35(4):888-94. PubMed ID: 21301835
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine.
Kang BW; Kim JG; Lee SJ; Chae YS; Moon JH; Sohn SK; Jeon SW; Jung MK; Lim KH; Jang YS; Park JS; Jun SH; Choi GS
Med Oncol; 2011 Dec; 28 Suppl 1():S214-8. PubMed ID: 20953739
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study.
Alwers E; Jansen L; Bläker H; Kloor M; Tagscherer KE; Roth W; Boakye D; Herpel E; Grüllich C; Chang-Claude J; Brenner H; Hoffmeister M
Mol Oncol; 2020 Feb; 14(2):363-372. PubMed ID: 31816156
[TBL] [Abstract][Full Text] [Related]
7. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726
[TBL] [Abstract][Full Text] [Related]
8. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma.
Elsaleh H; Iacopetta B
Clin Colorectal Cancer; 2001 Aug; 1(2):104-9. PubMed ID: 12445368
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer.
Lamberti C; Lundin S; Bogdanow M; Pagenstecher C; Friedrichs N; Büttner R; Sauerbruch T
Int J Colorectal Dis; 2007 Feb; 22(2):145-52. PubMed ID: 16724208
[TBL] [Abstract][Full Text] [Related]
11. Low-Level Microsatellite Instability as a Potential Prognostic Factor in Sporadic Colorectal Cancer.
Lee SY; Kim DW; Lee HS; Ihn MH; Oh HK; Min BS; Kim WR; Huh JW; Yun JA; Lee KY; Kim NK; Lee WY; Kim HC; Kang SB
Medicine (Baltimore); 2015 Dec; 94(50):e2260. PubMed ID: 26683947
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive significance of microsatellite instability in stage II colorectal carcinoma: An 8-year study from a tertiary center in South India.
Paulose RR; Ail DA; Biradar S; Vasudevan A; Sundaram KR
Indian J Cancer; 2019; 56(4):302-308. PubMed ID: 31607697
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of microsatellite instability in colorectal cancer: a Swedish multi-center study.
Rantanen P; Keränen A; Barot S; Ghazi S; Liljegren A; Nordenvall C; Lindblom A; Lindforss U
Int J Colorectal Dis; 2023 Jul; 38(1):197. PubMed ID: 37458848
[TBL] [Abstract][Full Text] [Related]
14. Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry.
Chong LC; Townsend AR; Young J; Roy A; Piantadosi C; Hardingham JE; Roder D; Karapetis C; Padbury R; Maddern G; Moore J; Price TJ
Target Oncol; 2019 Feb; 14(1):85-91. PubMed ID: 30659494
[TBL] [Abstract][Full Text] [Related]
15. The Association Between Mutations in BRAF and Colorectal Cancer-Specific Survival Depends on Microsatellite Status and Tumor Stage.
Bläker H; Alwers E; Arnold A; Herpel E; Tagscherer KE; Roth W; Jansen L; Walter V; Kloor M; Chang-Claude J; Brenner H; Hoffmeister M
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):455-462.e6. PubMed ID: 29660527
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy.
Hemminki A; Mecklin JP; Järvinen H; Aaltonen LA; Joensuu H
Gastroenterology; 2000 Oct; 119(4):921-8. PubMed ID: 11040179
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Significance of Microsatellite Instability in Patients with Right-sided Colorectal Cancer.
Han SA; Kim JH; Choi JH; Lee DH; Jung K; Kim SE; Moon W; Park MI; Park SJ
Korean J Gastroenterol; 2019 Mar; 73(3):159-166. PubMed ID: 31013559
[TBL] [Abstract][Full Text] [Related]
18. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).
Goldstein J; Tran B; Ensor J; Gibbs P; Wong HL; Wong SF; Vilar E; Tie J; Broaddus R; Kopetz S; Desai J; Overman MJ
Ann Oncol; 2014 May; 25(5):1032-8. PubMed ID: 24585723
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial.
Klingbiel D; Saridaki Z; Roth AD; Bosman FT; Delorenzi M; Tejpar S
Ann Oncol; 2015 Jan; 26(1):126-132. PubMed ID: 25361982
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability & survival in patients with stage II/III colorectal carcinoma.
Srdjan M; Jadranka A; Ivan D; Branimir Z; Daniela B; Petar S; Velimir M; Zoran K
Indian J Med Res; 2016 May; 143(Supplement):S104-S111. PubMed ID: 27748284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
